Clinical TrialsOcugen Completes GARDian3 Dosing for OCU410ST in Stargardt Disease Ocugen Completes GARDian3 Dosing for OCU410ST in Stargardt Disease Read Post »
Clinical TrialsAstra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Astra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Read Post »
Clinical TrialsConnect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Connect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Read Post »
Clinical TrialsUnited Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... United Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... Read Post »
Clinical TrialsMerck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Merck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Read Post »
Clinical TrialsTanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Tanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Read Post »
Clinical TrialsWith 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... With 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... Read Post »
Clinical TrialsConnect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Connect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Read Post »
Clinical TrialsBeyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Beyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Read Post »
Clinical TrialsBMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... BMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... Read Post »
Clinical TrialsBiogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Biogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Read Post »
Clinical TrialsTakeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Read Post »
Clinical TrialsIncyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Incyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Read Post »
Clinical TrialsTaltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Taltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Read Post »
Clinical TrialsLilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Lilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Read Post »
Clinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Sanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Read Post »
Clinical TrialsLenvima, Welireg Moves Closer to Approval with Japan Submission Lenvima, Welireg Moves Closer to Approval with Japan Submission Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD AstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD Read Post »
Clinical TrialsWave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Wave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Read Post »
Clinical TrialsEncoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Encoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Read Post »
Clinical TrialsCompass Updates COMP360 Pipeline, Targets FDA Filing in TRD Compass Updates COMP360 Pipeline, Targets FDA Filing in TRD Read Post »
Clinical TrialsInnovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Innovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Read Post »
Clinical TrialsSarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Sarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Read Post »
Clinical TrialsNovo Nordisk, TUL Report Positive UBT251 Phase 2 Results Novo Nordisk, TUL Report Positive UBT251 Phase 2 Results Read Post »
Clinical TrialsOcugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Ocugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Read Post »
Clinical TrialsDizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Dizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Read Post »
Clinical TrialsApogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Apogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Read Post »
Clinical TrialsFDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... FDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... Read Post »
Clinical TrialsInsmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Insmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Read Post »
Clinical TrialsPfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Pfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Read Post »
Clinical TrialsRoche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Roche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Read Post »
Clinical TrialsBiohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Biohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Read Post »
Clinical TrialsBiogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Biogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Read Post »
Clinical TrialsSerum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Serum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Read Post »
Clinical TrialsChugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Chugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Read Post »
Clinical TrialsPfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Pfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Read Post »
Clinical TrialsSobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Sobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Read Post »
Clinical TrialsRhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Rhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Read Post »
Clinical TrialsPfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Pfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Read Post »
Clinical TrialsFDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... FDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... Read Post »
Clinical TrialsStructure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Structure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Read Post »
Clinical TrialsLilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Lilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Read Post »
Clinical TrialsCytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data CytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data Read Post »
Clinical TrialsBayer Reports Positive Phase III FIND-CKD Results for Finerenone Bayer Reports Positive Phase III FIND-CKD Results for Finerenone Read Post »
Clinical TrialsFDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... FDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... Read Post »
Clinical TrialsNRx Targets FDA Approval for NRX-100 in Severe Depression NRx Targets FDA Approval for NRX-100 in Severe Depression Read Post »
Clinical TrialsAbbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Abbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Read Post »
Clinical TrialsOtsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Otsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Read Post »
Clinical TrialsUnited’s Tyvaso Delivers Positive Phase 3 Results in IPF United’s Tyvaso Delivers Positive Phase 3 Results in IPF Read Post »
Clinical TrialsCapricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Capricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Read Post »
